HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Benjamin G Neel Selected Research
Benjamin G Neel Research Topics
Disease
55
Neoplasms (Cancer)
09/2023 - 09/2002
15
Obesity
11/2022 - 04/2002
15
Noonan Syndrome (Female Pseudo-Turner Syndrome)
01/2021 - 08/2004
12
Insulin Resistance
01/2021 - 01/2004
10
Breast Neoplasms (Breast Cancer)
09/2023 - 08/2002
9
Leukemia
01/2023 - 03/2004
8
Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 02/2012
5
Inflammation (Inflammations)
01/2021 - 01/2007
5
Hypersensitivity (Allergy)
09/2014 - 04/2002
4
Lung Neoplasms (Lung Cancer)
02/2024 - 05/2010
4
Inborn Genetic Diseases (Disease, Hereditary)
01/2020 - 09/2005
4
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018 - 03/2008
4
LEOPARD Syndrome (Syndrome, LEOPARD)
01/2018 - 05/2010
4
Carcinogenesis
01/2016 - 09/2002
3
Moyamoya Disease (Moya-Moya Disease)
09/2023 - 01/2016
3
Hypoxia (Hypoxemia)
09/2023 - 01/2012
3
Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2005
3
Neuroblastoma
01/2017 - 12/2004
2
Adenocarcinoma
02/2024 - 08/2015
2
Carcinoma (Carcinomatosis)
01/2021 - 03/2008
2
Thrombosis (Thrombus)
12/2019 - 08/2005
2
Hematologic Neoplasms (Hematological Malignancy)
01/2017 - 04/2016
2
Hypertrophy
01/2017 - 07/2005
2
Weight Loss (Weight Reduction)
01/2015 - 09/2014
2
Weight Gain
09/2014 - 11/2011
2
Neurofibromatosis 1 (Neurofibromatosis Type I)
08/2014 - 03/2013
2
Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2013 - 03/2009
2
Body Weight (Weight, Body)
01/2012 - 08/2006
2
Juvenile Myelomonocytic Leukemia
11/2010 - 04/2009
2
Melanoma (Melanoma, Malignant)
09/2010 - 09/2002
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2024
1
Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2022
1
Splenomegaly
10/2021
1
Polycythemia (Erythrocytosis)
10/2021
1
Genomic Instability
11/2020
1
Neurodevelopmental Disorders
01/2020
Drug/Important Bio-Agent (IBA)
18
Proteins (Proteins, Gene)
FDA Link
09/2023 - 08/2002
17
Protein Tyrosine Phosphatases
IBA
01/2020 - 04/2002
16
Tyrosine (L-Tyrosine)
FDA Link
01/2021 - 08/2002
13
Insulin (Novolin)
FDA Link
01/2022 - 04/2002
10
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
01/2020 - 06/2004
9
Leptin
IBA
11/2022 - 04/2002
9
Glucose (Dextrose)
FDA Link
Generic
01/2021 - 01/2004
9
Non-Receptor Type 1 Protein Tyrosine Phosphatase
IBA
07/2013 - 06/2004
8
Non-Receptor Type 11 Protein Tyrosine Phosphatase
IBA
01/2021 - 01/2007
7
Phosphotransferases (Kinase)
IBA
01/2020 - 09/2002
6
6-pyruvoyltetrahydropterin synthase (PTPS)
IBA
01/2017 - 06/2004
5
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
11/2015 - 01/2007
4
Biomarkers (Surrogate Marker)
IBA
02/2024 - 04/2013
4
DNA (Deoxyribonucleic Acid)
IBA
09/2017 - 07/2007
4
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
05/2015 - 08/2002
3
Antibodies
IBA
01/2023 - 07/2007
3
Ascorbic Acid (Vitamin C)
FDA Link
Generic
01/2023 - 09/2017
3
Ligands
IBA
01/2022 - 10/2018
3
Tyrosine Kinase Inhibitors
IBA
01/2022 - 08/2015
3
Antineoplastic Agents (Antineoplastics)
IBA
01/2018 - 12/2004
3
Cytokines
IBA
01/2017 - 11/2006
3
ErbB Receptors (EGF Receptor)
IBA
08/2015 - 01/2003
2
sotorasib
IBA
02/2024 - 01/2023
2
ATPases Associated with Diverse Cellular Activities
IBA
09/2023 - 01/2022
2
RNA (Ribonucleic Acid)
IBA
01/2022 - 09/2015
2
Lipids
IBA
01/2021 - 05/2014
2
Phenobarbital (Luminal)
FDA Link
11/2020 - 01/2016
2
Transcription Factors (Transcription Factor)
IBA
01/2020 - 07/2005
2
tyrosine receptor (receptor, tyrosine)
IBA
01/2020 - 10/2018
2
Mitogen-Activated Protein Kinases
IBA
01/2020 - 03/2008
2
Reactive Oxygen Species (Oxygen Radicals)
IBA
11/2019 - 01/2011
2
Dioxygenases
IBA
09/2017 - 01/2016
2
Phosphotyrosine
IBA
01/2017 - 01/2015
2
Small Interfering RNA (siRNA)
IBA
01/2016 - 02/2012
2
GTP Phosphohydrolases (GTPases)
IBA
05/2015 - 03/2013
2
Growth Hormone (Somatotropin)
IBA
07/2014 - 03/2012
2
Parathyroid Hormone-Related Protein
IBA
07/2013 - 01/2013
2
Integrins
IBA
03/2013 - 02/2004
2
Insulin Receptor
IBA
01/2012 - 08/2007
2
Sirolimus (Rapamycin)
FDA Link
03/2011 - 03/2004
2
Messenger RNA (mRNA)
IBA
05/2010 - 08/2002
2
Phosphatidylinositols (Phosphatidylinositol)
IBA
07/2005 - 09/2002
1
adagrasib
IBA
02/2024
1
Ligases (Synthetase)
IBA
09/2023
1
Ubiquitin
IBA
09/2023
1
Adenosine Diphosphate Ribose (ADP-Ribose)
IBA
04/2023
1
NAD (NADH)
IBA
04/2023
1
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
04/2023
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2023
1
Haptens
IBA
01/2023
1
5-Methylcytosine (5 Methylcytosine)
IBA
01/2023
1
Peptides (Polypeptides)
IBA
01/2023
1
Leptin Receptors
IBA
01/2022
1
ruxolitinib
IBA
10/2021
1
Hypoglycemic Agents (Hypoglycemics)
IBA
01/2021
1
Follistatin
IBA
01/2021
1
DNA-Directed DNA Polymerase (Polymerases, DNA)
IBA
11/2020
1
DNA Repair Enzymes
IBA
11/2020
1
Isoenzymes
IBA
01/2020
1
phenothiazine
IBA
01/2020
1
Collagen
IBA
12/2019
Therapy/Procedure
19
Therapeutics
02/2024 - 12/2004
4
Immunotherapy
01/2023 - 04/2019
4
Drug Therapy (Chemotherapy)
01/2021 - 01/2011